期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

泌尿男生殖系肿瘤第七版TNM分期的变化及解读 被引量：10

原文传递
导出
摘要 目前，恶性肿瘤已成为威胁人类健康与生命的主要疾病之一。在发达国家，恶性肿瘤是国民死亡的首要原因。在我国，恶性肿瘤占城市居民死因的第一位，在农村居民的死因中也呈上升趋势。
作者 孔德波 谢立平
机构地区 浙江大学医学院附属第一医院泌尿外科
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2012年第2期149-151,共3页 Chinese Journal of Urology
关键词 TNM分期 生殖系肿瘤 解读 泌尿 恶性肿瘤 人类健康 发达国家 城市居民
分类号 R737.1 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61: 69-90.
  • 2Farges O, Fuks D, Le Treut YP, et al. AJCC 7th edition of TNM staging accu- rately discriminates outcomes of patients with resectable intrahepatic cholangiocar- cinoma: by the AFC-IHCC-2009 study group. Cancer, 2011, 117: 2170-2177.
  • 3Hong KD, Lee SI, Moon HY. Lymph node ratio as determined by the 7th edi- tion of the Ameriean Joint Committee on Cancer staging system predicts survival in stage III colon cancer. J Surg Oncol', 2011, 103: 406-410.
  • 4Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. Singapore: Wiley- Blackwell, 2009.
  • 5Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual 7th ed. New York: Springer Verlag, 2010.
  • 6牛海涛,孙光.根治性膀胱切除手术预后评价的研究进展[J].中华泌尿外科杂志,2011,32(10):718-720. 被引量：4
  • 7Lotan Y, Gupta A, Shariat SF, et al. Lymphovascular invasion is independent- ly associated with overall survival, cause-specific survival, and local and distant recurrence in patients with nega- tive lymph nodes at radical cystectomy. J Clin Oncol, 2005, 23: 6533-6539.
  • 8Bhagat SK, Gopalakrishnan G, Kekre NS, et al. Factors predicting inguinal node metastasis in squamous cell cancer of penis. World J Urol, 2010, 28: 93- 98.
  • 9Thuret R, Sun M, Abdollah F, et al. Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile car- cinoma. J Urol, 2011, 185: 501-507.
  • 10Deem S, Keane T, Bhavsar R, et al. Contemporary diagnosis and management of squamous cell carcinoma (SCC) of the penis. BJU Int, 2011, 108: 1378- 1392.

二级参考文献20

  • 1Shariat SF, Palapattu GS, Karakiewicz PI, et al. Discrepancy between clinical and pathologic stage: impact on progno- sis after radical cystcctomy. Eur Urol, 2007, 51: 137-149.
  • 2Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term re- suits in 1054 patients. J Clin Oncol, 2001, 19 : 666-675.
  • 3Kaufman DS, Shipley WU, Fcldnaan AS. madder cancer. Lancet, 2009, 374: 239 -249.
  • 4Bruins HM, Stein JP. Risk factors and clinical outcomes of patients with node- positive muscle-invasive bladder cancer. Expert Rev Anticancer Ther, 2008, 8: 1091-1101.
  • 5Stein JP. The role of lymphadenectomy in patients undergoing radical eystecto- my for bladder cancer. Curr Oncol Rep, 2007, 9: 213-221.
  • 6el-Mekresh M, Akl A, Mosbah A, et al. Prediction of survival after radical cystectomy for invasive bladder carcino- ma: risk group stratification, nomo- grams or artificial neural networks? J Urol, 2009, 182: 466-4-72.
  • 7Niu HT, Xu T, Zhang YB, et al. Out- comes for a large series of radical cystec- tomies for bladder cancer. Eur J Surg Oncol, 2008, 34: 911-915.
  • 8Rogers CG, Palapattu GS, Shariat SF, et al. Clinical outcomes following radical cystectomy for primary nontransitioaal cell carcinoma of the bladder compared to transitional cell carcinoma of the blad- der. J Urol, 2006, 175: 2048-2053.
  • 9Lee CT, Madii R, Daignauh S, et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis re- suits in decreased disease specific and o- verall survival. J Urol, 2006, 175: 1262-1267.
  • 10Sanchez-Ortiz RF, Huang WC, Mick R, et al. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol, 2003. 169, 110-115.

共引文献3

同被引文献88

  • 1Soichiro Yoshida,Fumitaka Koga,Shuichiro Kobayashi,Hiroshi Tanaka,Shiro Satoh,Yasuhisa Fujii,Kazunori Kihara.Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy[J].World Journal of Radiology,2014,6(6):344-354. 被引量：2
  • 2方祖军,燕翔,郑捷,杨醌,陈波,姚孟树,丁强,张元芳.肾癌的病理类型与预后的关系[J].临床泌尿外科杂志,2006,21(4):262-263. 被引量：22
  • 3Siegel R,Naishadham D,Jemal A.Cancer statistics,2013.CA Cancer J Clin,2013,63:11-30.
  • 4Smith MR,Saad F,Coleman R,et al.Denosumab and bonemetastasis-free survival in men with castration-resistant prostate cancer:results of a phase 3,randomised,placebo-controlled trial.Lancet,2012,379:39-46.
  • 5Makarov DV,Trock BJ,Humphreys EB,et al.Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level,clinical stage,and biopsy Gleason score (Partin tables)based on cases from 2000 to 2005.Urology,2007,69:1095-1101.
  • 6Jeldres C,Suardi N,Walz J,et al.Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.Eur Urol,2008,54:1306-1313.
  • 7Stephenson AJ,Kattan MW,Eastham JA,et al.Prostate cancerspecific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.J Clin Oncol,2009,27:4300-4305.
  • 8Cagiannos I,Karakiewicz P,Eastham JA,et al.A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.J Urol,2003,170:1798-1803.
  • 9Tosoian J J,Trock B J,Landis P,et al.Active surveillance program for prostate cancer:an update of the Johns Hopkins experience.J Clin Oneol,2011,29:2185-2190.
  • 10Kitagawa Y,Ueno S,Izumi K,et al.Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1-10.0 ng/ml at population screening.J Cancer Res Clin Oncol,2013 Oct 29.[Epub ahead of print].

引证文献10

二级引证文献66

中华泌尿外科杂志
2012年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部